Evidence map›Paper›PMID 28012897›Full record

ArticleJournal of virological methods2017

Visualization of herpes simplex virus type 1 virions using fluorescent colors.

Lyns Etienne, Poorval Joshi, Laura Dingle, Eugene Huang, Peter Grzesik, Prashant J Desai

Open access · greenAbstract read
In one paragraph

Article in Journal of virological methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Cellular antibody affinity-based CRISPR screening identifies JUNB as a broadly acting antiviral factor.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lyns EtienneDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Poorval JoshiDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Laura DingleDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eugene HuangDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Peter GrzesikDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Prashant J DesaiDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: pdesai@jhmi.edu.
Johns Hopkins University · USSidney Kimmel Comprehensive Cancer Center · US

Funding

MOLECULAR GENETICS OF HSV-1 CAPSIDSR01AI033077 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DESAI, PRASHANT · 1994 to 2007
$2.5M
Maturation functions of the HSV-1 tegumentR01AI061382 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DESAI, PRASHANT J · 2006 to 2010
$1.8M
How does the KSHV small capsid protein function to promote self-assembly?R21AI107530 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DESAI, PRASHANT J · 2013 to 2014
$431k
Bridging KSHV capsids to the nuclear egress complexR21AI107537 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DESAI, PRASHANT J · 2013 to 2014
$431k
NIAID NIH HHS R01 AI033077NIAID NIH HHS R01 AI061382NIAID NIH HHS R21 AI107530NIAID NIH HHS R21 AI107537
6 · The paper itself

Abstract

Our laboratory was one of the first to engineer a live fluorescent tag, enhanced green fluorescent protein (eGFP), that marked the capsid of herpes simplex virus type 1 (HSV-1) and subsequently maturing virus as the particle made its way to the cell surface. In the present study we sought to increase the repertoire of colors available as fusion to the small capsid protein, VP26, so that they can be used alone or in conjunction with other fluorescent tags (fused to other HSV proteins) to follow the virus as it enters and replicates within the cell. We have now generated viruses expressing VP26 fusions with Cerulean, Venus, mOrange, tdTomato, mCherry, and Dronpa3 fluorescent proteins. These fusions were made in a repaired UL35 gene (VP26) background. These fusions do not affect the replication properties of the virus expressing the fusion polypeptide and the fusion tag was stably associated with intranuclear capsids and mature virions. Of note we could not isolate viruses expressing fusions with fluorescent proteins that have a tendency to dimerize.

Indexed as

AnimalsCapsid ProteinsCell LineCell MembraneChlorocebus aethiopsColorFluorescent DyesGreen Fluorescent ProteinsHerpesvirus 1, HumanLuminescent ProteinsProtein EngineeringRecombinant Fusion ProteinsRed Fluorescent ProteinVero CellsVirus ReplicationCapsid Proteinscapsid protein VP26, herpes simplex virus type 1enhanced green fluorescent proteinFluorescent Dyesfluorescent protein 583Green Fluorescent ProteinsLuminescent ProteinsRecombinant Fusion ProteinsRed Fluorescent ProteinCapsidFluorescent tagsHSV1tdTomatoVenusVP26

Identifiers

PMID28012897
PMCPMC5661875
OpenAlexW2564830693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.